180 related articles for article (PubMed ID: 8371149)
1. Antihyperglycemic action of guanidinoalkanoic acids: 3-guanidinopropionic acid ameliorates hyperglycemia in diabetic KKAy and C57BL6Job/ob mice and increases glucose disappearance in rhesus monkeys.
Meglasson MD; Wilson JM; Yu JH; Robinson DD; Wyse BM; de Souza CJ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1454-62. PubMed ID: 8371149
[TBL] [Abstract][Full Text] [Related]
2. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
3. Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway.
Zhang XL; Wang YN; Ma LY; Liu ZS; Ye F; Yang JH
Acta Pharmacol Sin; 2020 Mar; 41(3):383-393. PubMed ID: 31659239
[TBL] [Abstract][Full Text] [Related]
4. 4-Phenyl butyric acid does not generally reduce glucose levels in rodent models of diabetes.
Xu TY; Chen RH; Wang P; Zhang RY; Ke SF; Miao CY
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):441-6. PubMed ID: 19878212
[TBL] [Abstract][Full Text] [Related]
5. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
6. MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model.
Wang LY; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
J Ethnopharmacol; 2012 Aug; 143(1):347-54. PubMed ID: 22776833
[TBL] [Abstract][Full Text] [Related]
7. Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats.
Mokashi P; Bhatt LK; Khanna A; Pandita N
Biomed Pharmacother; 2017 Dec; 96():1427-1437. PubMed ID: 29031588
[TBL] [Abstract][Full Text] [Related]
8. Des-aspartate-angiotensin I exerts hypoglycemic action via glucose transporter-4 translocation in type 2 diabetic KKAy mice and GK rats.
Sim MK; Xu XG; Wong YC; Sim SZ; Lee KO
Endocrinology; 2007 Dec; 148(12):5925-32. PubMed ID: 17823251
[TBL] [Abstract][Full Text] [Related]
9. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
[TBL] [Abstract][Full Text] [Related]
10. (-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus.
Freund P; Wolff HP; Kühnle HF
Metabolism; 1995 May; 44(5):570-6. PubMed ID: 7752903
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.
Alberts P; Nilsson C; Selen G; Engblom LO; Edling NH; Norling S; Klingström G; Larsson C; Forsgren M; Ashkzari M; Nilsson CE; Fiedler M; Bergqvist E; Ohman B; Björkstrand E; Abrahmsen LB
Endocrinology; 2003 Nov; 144(11):4755-62. PubMed ID: 12960099
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats.
Farrace S; Rossetti L
Diabetes; 1992 Nov; 41(11):1453-63. PubMed ID: 1397721
[TBL] [Abstract][Full Text] [Related]
13. Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice.
O'Harte FP; Mooney MH; Kelly CM; McKillop AM; Flatt PR
Regul Pept; 2001 Jan; 96(3):95-104. PubMed ID: 11111014
[TBL] [Abstract][Full Text] [Related]
14. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
15. Effects of Agriophyllum squarrosum extracts on glucose metabolism in KKAy mice and the associated underlying mechanisms.
Saqier ; Bao S; Han S; Ao W
J Ethnopharmacol; 2019 Sep; 241():112009. PubMed ID: 31158442
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
Zhang X; Zhuang Y; Qin T; Chang M; Ji X; Wang N; Zhang Z; Zhou H; Wang Q; Li JZ
Metabolism; 2021 Sep; 122():154823. PubMed ID: 34197875
[TBL] [Abstract][Full Text] [Related]
17. Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.
Kim DY; Kim SR; Jung UJ
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182914
[TBL] [Abstract][Full Text] [Related]
18. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
[TBL] [Abstract][Full Text] [Related]
19. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
[TBL] [Abstract][Full Text] [Related]
20. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]